Analyst Activity – Cann Reiterates Buy on NASDAQ:SYRS – Syros Pharmaceuticals (NASDAQ:SYRS)

ME Staff
-
0

Analyst Ratings For NASDAQ:SYRS – Syros Pharmaceuticals (NASDAQ:SYRS)

Today, Cann reiterated its Buy rating on NASDAQ:SYRS – Syros Pharmaceuticals (NASDAQ:SYRS) with a price target of $28.00.

Some recent analyst ratings include

  • 5/10/2018-Cann Reiterated Rating of Buy.
  • 3/14/2018-HC Wainwright Reiterated Rating of Hold.
  • 3/13/2018-Wedbush Reiterated Rating of Outperform ➝ Outperform.
  • 12/11/2017-Cowen Reiterated Rating of Buy.
  • 10/31/2017-Piper Jaffray Reiterated Rating of Overweight ➝ Overweight.
  • 10/23/2017-Roth Capital initiated coverage with a Neutral ➝ Neutral rating.

Recent Insider Trading Activity For NASDAQ:SYRS – Syros Pharmaceuticals (NASDAQ:SYRS)
NASDAQ:SYRS – Syros Pharmaceuticals (NASDAQ:SYRS) has insider ownership of 27.80% and institutional ownership of 48.85%.

  • On 1/31/2018 Srinivas Akkaraju, Director, bought 209,424 with an average share price of $9.55 per share and the total transaction amounting to $1,999,999.20.
  • On 12/15/2017 Jeremy P Springhorn, Insider, bought 15,000 with an average share price of $9.08 per share and the total transaction amounting to $136,200.00.
  • On 12/14/2017 Srinivas Akkaraju, Director, bought 109,774 with an average share price of $9.03 per share and the total transaction amounting to $991,259.22.
  • On 10/23/2017 Colleen Elizabeth Desimone, Insider, sold 550 with an average share price of $16.06 per share and the total transaction amounting to $8,833.00.
  • On 8/14/2017 Richard A Young, Director, sold 3,282 with an average share price of $22.00 per share and the total transaction amounting to $72,204.00.
  • On 8/7/2017 Eric R Olson, Insider, sold 2,500 with an average share price of $23.59 per share and the total transaction amounting to $58,975.00.
  • On 7/25/2017 Eric R Olson, Insider, sold 12,500 with an average share price of $21.85 per share and the total transaction amounting to $273,125.00.

Recent Trading Activity for NASDAQ:SYRS – Syros Pharmaceuticals (NASDAQ:SYRS)
Shares of NASDAQ:SYRS – Syros Pharmaceuticals closed the previous trading session at 11.84 down -0.34 2.79% with 12.119999885559082 shares trading hands.